Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study
ConclusionAt one year, clinical outcomes with the SYNTAX-II strategy were associated with improved clinical results compared to the PCI performed in comparable patients from the original SYNTAX-I trial. Longer term follow-up is awaited and a randomized clinical trial with contemporary CABG is warranted.ClinicalTrials.gov IdentifierNCT02015832
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Cardiology | Clinical Trials | Coronary Angioplasty | Coronary Artery Bypass Graft | Heart | Heart Attack | History of Medicine | Percutaneous Coronary Intervention | Physiology | Stroke | Study | Thrombosis | Ultrasound